Covaxin Coronavirus Vaccine
-
{
- All
- News
- Videos
-
"Covaxin Safe For Kids Aged 2-18": Here's What Bharat Biotech Says On Side-Effects
Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
-
No Nod For Covaxin Yet, WHO Seeks "Additional Clarifications"
The World Health Organisation's technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.
-
Expect WHO Nod To Covaxin In July-Sept: Bharat Biotech Amid Travel Fears
As countries prep to gradually restart travel and tourism after prolonged Covid restrictions, there is nervousness among students about the World Health Organisation and many countries not listing Bharat Biotech's Covaxin among approved vaccines.
-
Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report
Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.
-
Nepal Becomes Third Country To Give Emergency Nod To India's Covaxin
Nepal on Friday gave emergency authorisation to India's COVID-19 vaccine COVAXIN, becoming only the third country to approve the shot, developed by Bharat Biotech and a state research institute.
-
Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet
Covaxin, the homegrown coronavirus vaccine that was authorized for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has published its phase 2 results.
-
Kerala Chief Minister Urges People To Take Covaxin Without Hesitation
Kerala Chief Minister Pinarayi Vijayan on Thursday urged people to take the indigenous Covaxin vaccine without any hesitation on the basis of the latest report of the Indian Council of Medical Research, the country's top research body, about its third phase clinical trials.
-
Give Option To Choose Vaccine: Karnataka Resident Doctors To Centre
The president of the Karnataka Association of Resident Doctors, Dr Dayanand Sagar on Tuesday raised concern over the COVID-19 vaccine Covaxin.
-
"Don't Accuse Us Of Inexperience, We Are Global Company": Bharat Biotech
The chairman of Bharat Biotech - whose coronavirus vaccine Covaxin was yesterday given "restricted use in emergency situation in public interest" - hit out today at critics querying the lack of Phase III trial data and others questioning the drug's efficacy
-
Bharat Biotech's Vaccine Cleared By Panel, Regulator's Approval Awaited
Covaxin, the coronavirus vaccine from Hyderabad-based Bharat Biotech, has been recommended for "restricted use in emergency situation, " by a government-appointed panel, which submitted its findings to the Drugs Controller General of India
-
Haryana Minister Anil Vij Becomes First Volunteer Of Covid Vaccine Trials
Haryana Health Minister Anil Vij was administered a trial dose of a coronavirus vaccine today in a hospital in the state's Ambala Cantonment. The third phase trial of Bharat Biotech's Covaxin began in Haryana today.
-
COVAXIN, India's First COVID-19 Vaccine Candidate, Set For Phase I, II Human Trials
A potential COVID-19 vaccine, the first to be developed in India, has been given approval for Phase I and II human clinical trials scheduled to start in July
-
"Covaxin Safe For Kids Aged 2-18": Here's What Bharat Biotech Says On Side-Effects
Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
-
No Nod For Covaxin Yet, WHO Seeks "Additional Clarifications"
The World Health Organisation's technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.
-
Expect WHO Nod To Covaxin In July-Sept: Bharat Biotech Amid Travel Fears
As countries prep to gradually restart travel and tourism after prolonged Covid restrictions, there is nervousness among students about the World Health Organisation and many countries not listing Bharat Biotech's Covaxin among approved vaccines.
-
Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report
Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.
-
Nepal Becomes Third Country To Give Emergency Nod To India's Covaxin
Nepal on Friday gave emergency authorisation to India's COVID-19 vaccine COVAXIN, becoming only the third country to approve the shot, developed by Bharat Biotech and a state research institute.
-
Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet
Covaxin, the homegrown coronavirus vaccine that was authorized for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has published its phase 2 results.
-
Kerala Chief Minister Urges People To Take Covaxin Without Hesitation
Kerala Chief Minister Pinarayi Vijayan on Thursday urged people to take the indigenous Covaxin vaccine without any hesitation on the basis of the latest report of the Indian Council of Medical Research, the country's top research body, about its third phase clinical trials.
-
Give Option To Choose Vaccine: Karnataka Resident Doctors To Centre
The president of the Karnataka Association of Resident Doctors, Dr Dayanand Sagar on Tuesday raised concern over the COVID-19 vaccine Covaxin.
-
"Don't Accuse Us Of Inexperience, We Are Global Company": Bharat Biotech
The chairman of Bharat Biotech - whose coronavirus vaccine Covaxin was yesterday given "restricted use in emergency situation in public interest" - hit out today at critics querying the lack of Phase III trial data and others questioning the drug's efficacy
-
Bharat Biotech's Vaccine Cleared By Panel, Regulator's Approval Awaited
Covaxin, the coronavirus vaccine from Hyderabad-based Bharat Biotech, has been recommended for "restricted use in emergency situation, " by a government-appointed panel, which submitted its findings to the Drugs Controller General of India
-
Haryana Minister Anil Vij Becomes First Volunteer Of Covid Vaccine Trials
Haryana Health Minister Anil Vij was administered a trial dose of a coronavirus vaccine today in a hospital in the state's Ambala Cantonment. The third phase trial of Bharat Biotech's Covaxin began in Haryana today.
-
COVAXIN, India's First COVID-19 Vaccine Candidate, Set For Phase I, II Human Trials
A potential COVID-19 vaccine, the first to be developed in India, has been given approval for Phase I and II human clinical trials scheduled to start in July
